SpringWorks Therapeutics Inc (SWTX)
39.03
+2.73
(+7.52%)
USD |
NASDAQ |
Nov 22, 16:00
39.00
-0.03
(-0.08%)
After-Hours: 20:00
SpringWorks Therapeutics Total Liabilities (Quarterly): 76.30M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 76.30M |
| June 30, 2024 | 60.60M |
| March 31, 2024 | 89.39M |
| December 31, 2023 | 99.57M |
| September 30, 2023 | 72.76M |
| June 30, 2023 | 65.89M |
| March 31, 2023 | 62.27M |
| December 31, 2022 | 72.05M |
| September 30, 2022 | 69.15M |
| June 30, 2022 | 40.18M |
| March 31, 2022 | 28.78M |
| December 31, 2021 | 30.10M |
| Date | Value |
|---|---|
| September 30, 2021 | 28.60M |
| June 30, 2021 | 23.84M |
| March 31, 2021 | 19.89M |
| December 31, 2020 | 19.13M |
| September 30, 2020 | 13.34M |
| June 30, 2020 | 10.15M |
| March 31, 2020 | 9.274M |
| December 31, 2019 | 12.76M |
| September 30, 2019 | 11.08M |
| June 30, 2019 | 11.00M |
| December 31, 2018 | 67.76M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.274M
Minimum
Mar 2020
99.57M
Maximum
Dec 2023
45.20M
Average
35.14M
Median
Total Liabilities (Quarterly) Benchmarks
| Ocugen Inc | 21.31M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 608.88M |
| Shareholders Equity (Quarterly) | 532.58M |
| Current Ratio | 6.162 |